Dublin, May 26, 2022 (GLOBE NEWSWIRE) -- The " Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, Gi Etc.) by Place, by Product and by Country. With ...

Dublin, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The "Syndromic Multiplex Panels Market 2025-2029 - Strategies, Trends and Forecasts by Syndrome (Respiratory, Sepsis, Gi, Other), Place, Product and Country, ...

Acute gastroenteritis afflicts adults of all ages, causing significant suffering and inflicting significant costs on the American healthcare system. A new study encompassing nearly 40,000 hospital ...

Dublin, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The " Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, Gi Etc.) by Place, by Product and by Country.

Prostate-specific antigen (PSA) progression-free survival (PFS): A comparison of degarelix versus leuprolide in patients with prostate cancer. Background: Prostate cancer (PCa) is the second leading ...

DUBLIN--(BUSINESS WIRE)--The " Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, Gi Etc.) by Place, by Product and by Country. With Market Analysis ...

Background. Molecular syndromic diagnostic panels can enhance pathogen identification in the approximately 2–4 billion episodes of acute gastroenteritis that occur annually worldwide. However, the ...

There are new generations of comprehensive multiplex molecular panels available for infectious diseases syndromic diagnostics. They are able to rapidly detect and identify the most common pathogens in ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the Bio-Plex Pro Human IgG SARS-CoV-2 N/RBD/S1 ...

Aushon BioSystems, Inc. has launched new Human multiplex biomarker panels for the quantification of eight biomarkers related to drug-induced kidney damage, or nephrotoxicity. Recent studies ...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC) with varying capacities to evade vaccine-induced immunity continue to emerge, the latest one being the B.1.1.529 ...